MedPath

PHL-OLANZAPINE

PHL-OLANZAPINE

Discontinued
DIN Number

02307448

Drug Class

Human

Market Date

Feb 18, 2010

Company
HC

pharmel inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02307448
AIG Number0128783002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05AH03 OLANZAPINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:16.08.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

OLANZAPINEActive
Strength: 10 MG
Monograph: OLANZAPINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.